Epicyte Pharmaceutical, Inc.

San Diego, CA 92121

SBIR Award Summary

Total Number of Awards 12
Total Value of Awards $4.21MM
First Award Date 09/15/00
Most Recent Award Date 09/01/02

Key Personnel

Last Name Name Awards Contact
Whaley Kevin John Whaley 10
Radomsky Michael L. Radomsky 1
Zeitlin Larry Zeitlin 24 Message

12 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/02 - 08/31/03

DESCRIPTION: (Provided by Applicant) The objective of this project is to produce human antibodies and antibody hybrids in plants (plantibodies)) to meet the market needs (low cost, large capacity) of a vaginal microbicide for preventing the sexual transmission of human immunodeficiency virus (HIV). Since the mechanisms of sexual transmission of ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PAR-98-073
Budget: 09/01/02 - 11/01/03

DESCRIPTION (provided by applicant): The objective of this project is to develop antibodies specific for human immunodeficiency virus (HIV) that can be used in a vaginal microbicide for preventing sexual transmission of HIV. These HIV antibodies can be combined with antibodies against other sexually transmi...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PAR-98-073
Budget: 09/01/02 - 12/31/03

DESCRIPTION (Verbatim from Applicant's Abstract): Local delivery of antibodies to the reproductive tract can block sperm and sexually transmitted pathogens to prevent pregnancy or infection. Recent advances in monoclonal antibody technology make it possible to produce large quantities of inexpensive antibo...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/02 - 12/31/03

The overall-goal is to develop plantibody-based microbicides that can be used in consumer products for the prevention of sexual transmission of diseases (STDs), as well as gastrointestinal and respiratory diseases. 'The potency and specificity of antibodies make them ideal agents for incorporation into a sexual lubricant. We have previously esta...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PAR-98-073
Budget: 05/01/02 - 04/30/03

DESCRIPTION (Verbatim from Applicant's Abstract): An evolving strategy for the prevention of sexually transmitted diseases is the development of broad spectrum vaginal microbicides. Many of these microbicides (e.g. detergents like nonoxynol-9) have mechanisms of action that are not limited to specific pathoge...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PAR-98-073
Budget: 09/20/01 - 08/31/02

DESCRIPTION (provided by applicant): The objective of this project is to develop antibodies specific for human immunodeficiency virus (HIV) that can be used in a vaginal microbicide for preventing sexual transmission of HIV. These HIV antibodies can be combined with antibodies against other sexually transmi...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PAR-98-073
Budget: 09/15/01 - 08/31/02

DESCRIPTION (Verbatim from Applicant's Abstract): Local delivery of antibodies to the reproductive tract can block sperm and sexually transmitted pathogens to prevent pregnancy or infection. Recent advances in monoclonal antibody technology make it possible to produce large quantities of inexpensive antibo...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/01 - 08/31/03

Human monoclonal antibodies are creating a new generation of pharmaceutical agents. They can now be produced at low cost and high volume in transgenic plants as "Plantibodies". Currently, EPIcyte is using transgenic corn to produce human plantibodies against sperm and HSV2 for protective reproductive health products. The aim of this proposal i...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/01 - 08/31/02

The overall-goal is to develop plantibody-based microbicides that can be used in consumer products for the prevention of sexual transmission of diseases (STDs), as well as gastrointestinal and respiratory diseases. 'The potency and specificity of antibodies make them ideal agents for incorporation into a sexual lubricant. We have previously esta...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PAR-98-073
Budget: 05/15/01 - 04/30/02

DESCRIPTION (Verbatim from Applicant's Abstract): An evolving strategy for the prevention of sexually transmitted diseases is the development of broad spectrum vaginal microbicides. Many of these microbicides (e.g. detergents like nonoxynol-9) have mechanisms of action that are not limited to specific pathoge...

Load More